Loss or Inhibition of Stromal-Derived PlGF Prolongs Survival of Mice with Imatinib-Resistant Bcr-Abl1+ Leukemia
Thomas Schmidt(Heidelberg University), Peter Carmeliet(Khalifa University of Science and Technology), Sonja Loges(German Cancer Research Center), Mieke Dewerchin(Vlaams Instituut voor Biotechnologie), Peter Fraisl(Vlaams Instituut voor Biotechnologie), Catherine M. Verfaillie(KU Leuven), Sandra Cauwenberghs(RWTH Aachen University), Andreas Hochhaus(Jena University Hospital), Bart Jonckx(VIB-KU Leuven Center for Cancer Biology), Tim H. Brümmendorf(National University Cancer Institute, Singapore), Tessa L. Holyoake(Gartnavel General Hospital), Michael Karin(Discovery Institute), Jan Cools(KU Leuven), Rita Fragoso, Stefan Vinckier(Vlaams Instituut voor Biotechnologie), Christa Maes(KU Leuven), Geert Carmeliet(KU Leuven), Sérgio Dias(University of Lisbon), Kim De Keersmaecker(VIB-KU Leuven Center for Cancer Biology), Peter Vandenberghe(KU Leuven), Behzad Kharabi Masouleh(Erytech Pharma (France)), Karolien Beel(KU Leuven), Shahin Rafii(Cornell University), Marc Tjwa, Maria Kleppe(Memorial Sloan Kettering Cancer Center), Thomas Schenk(Ludwig-Maximilians-Universität München), Maria De Mol(Vlaams Instituut voor Biotechnologie), Richard E. Clark(The Football Association)
Cited by 5
Related Papers
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
|Nature|1996|4.2k
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms
|Leukemia|2022|3.8k
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
|Cancer Cell|2005|3k
A cytokine-mediated link between innate immunity, inflammation, and cancer
|Journal of Clinical Investigation|2007|1.9k